Taken together, these results suggest that CD133 regulates MDR through the expression of MDR1/P-gp, and the AKT-NF-κB signalling pathway is the main mechanism by which CD133 regulates MDR1/P-gp expression in CRC. This evidence concerns the gene PROM1 and colorectal carcinoma.